See All Slides - tctmd.com

Slides

Presentation TCT 2024

Reflections on Innovation From a Recent FDA Leader

Presenter: William Maisel

October 27, 2024

Presentation TCT 2024

Is Aortic Regurgitation the Next Major TAVR Target?

Presenter: Duane Pinto

October 27, 2024

Presentation TCT 2024

Extending CV Innovation Beyond MedTech

Presenter: Peter Fitzgerald

October 27, 2024

Presentation TCT 2024

Worsening Heart Failure: How to Identify, How to Treat

Presenter: Cynthia Bither

October 27, 2024

Presentation TCT 2024

How to Recognize Amyloidosis and the Consequences of the Disease?

Presenter: Joban Vaishnav

October 27, 2024

Presentation TCT 2024

The RHC, What More Can It Tell Us

Presenter: Michele Gilbert

October 27, 2024

Presentation TCT 2024

Growing Role of AI in HF Diagnostics: Are There Any Pitfalls

Presenter: Partho Sengupta

October 27, 2024

Presentation TCT 2024

TCT 1351: Cangrelor in a Challenging Scenario of Concomitant Ischemic Stroke, Pulmonary Embolism and STEMI

Presenter: Federico Oliveri

October 27, 2024

Presentation TCT 2024

Impact of MitraClip on Hospitalization Rates in Symptomatic Patients With Heart Failure and Moderate to Severe Functional Mitral Regurgitation: Insights From RESHAPE-HF2

Presenter: Ralph von Bardeleben

October 27, 2024

Presentation TCT 2024

TCT 859: Impact of Aortic Valve Annular Dimensions Assessment in Various MDCT Systolic Phases on Optimization of Balloon Expandable TAVR Valve Size Selection and Valve Oversizing Percentage

Presenter: Denise Mourad

October 27, 2024

Advertisement

Slides

Reflections on Innovation From a Recent FDA Leader

Is Aortic Regurgitation the Next Major TAVR Target?

Extending CV Innovation Beyond MedTech

Worsening Heart Failure: How to Identify, How to Treat

How to Recognize Amyloidosis and the Consequences of the Disease?

The RHC, What More Can It Tell Us

Growing Role of AI in HF Diagnostics: Are There Any Pitfalls

TCT 1351: Cangrelor in a Challenging Scenario of Concomitant Ischemic Stroke, Pulmonary Embolism and STEMI

Impact of MitraClip on Hospitalization Rates in Symptomatic Patients With Heart Failure and Moderate to Severe Functional Mitral Regurgitation: Insights From RESHAPE-HF2

TCT 859: Impact of Aortic Valve Annular Dimensions Assessment in Various MDCT Systolic Phases on Optimization of Balloon Expandable TAVR Valve Size Selection and Valve Oversizing Percentage

Search Slides

Advertisement

Advertisement

Slides

Search Slides

Sign Up for Our Newsletter

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content